Navin is a partner in the Firm’s top-ranked Competition, Antitrust & Foreign Investment Group. Navin's clients rely on him for advice on domestic and multinational mergers, joint ventures, strategic alliances, cartels, abuse of dominance investigations, class actions and compliance programs. He is considered an expert on Canada's foreign investment laws and regulations, including those pertaining to national security and state-owned enterprises. Recent significant matters include: Standard Life in connection with its proposed acquisition by Manulife; GlaxoSmithKline in regarding its consumer healthcare, vaccines and oncology transactions with Novartis; Pearson PLC in connection with the Penguin Random House joint venture; and Visa Inc. in connection with Canadian competition law matters. Navin serves on the Executive Committee of the Canadian Bar Association's National Competition Law Section and is past chair of the Section's Legislation and Public Policy and Competition Litigation Committees. He is recognized as a leading lawyer in all major legal directories and ranking publications.